As previously reported, Rosenblatt analyst Blair Abernethy upgraded Synopsys (SNPS) to Buy from Neutral with a price target of $560, down from $605, ahead of the company reporting fiscal Q4 results after market close on December 10. Following a Q3 miss and guidance cut, the firm expects an in-line quarter, says the analyst, who notes the stock’s roughly 30% decline since the Q3 report on September 9.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys upgraded to Buy from Neutral at Rosenblatt
- Netflix, Tesla downgraded: Wall Street’s top analyst calls
- Options Volatility and Implied Earnings Moves This Week, December 08 – December 11, 2025
- Synopsys upgraded to Neutral at BofA ahead of FY26 guidance
- Synopsys upgraded to Neutral from Underperform at BofA